ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/11 | 2,004 | 2,004 | 1,930 | 1,944 | -65 | -3.2% | 168,400 |
2018/12/10 | 2,016 | 2,023 | 1,999 | 2,009 | -23 | -1.1% | 81,100 |
2018/12/07 | 2,019 | 2,036 | 2,001 | 2,032 | +21 | +1% | 87,800 |
2018/12/06 | 2,003 | 2,018 | 1,981 | 2,011 | -25 | -1.2% | 133,200 |
2018/12/05 | 2,011 | 2,052 | 2,002 | 2,036 | +3 | +0.1% | 106,700 |
2018/12/04 | 2,103 | 2,105 | 2,031 | 2,033 | -71 | -3.4% | 140,400 |
2018/12/03 | 2,120 | 2,130 | 2,084 | 2,104 | ±0 | ±0% | 87,700 |
2018/11/30 | 2,069 | 2,119 | 2,058 | 2,104 | +38 | +1.8% | 111,300 |
2018/11/29 | 2,092 | 2,092 | 2,057 | 2,066 | -20 | -1% | 102,600 |
2018/11/28 | 2,078 | 2,092 | 2,059 | 2,086 | +8 | +0.4% | 76,200 |
2018/11/27 | 2,102 | 2,103 | 2,069 | 2,078 | -24 | -1.1% | 64,300 |
2018/11/26 | 2,109 | 2,111 | 2,077 | 2,102 | -7 | -0.3% | 60,800 |
2018/11/22 | 2,078 | 2,113 | 2,065 | 2,109 | +32 | +1.5% | 51,200 |
2018/11/21 | 2,075 | 2,094 | 2,058 | 2,077 | -25 | -1.2% | 90,700 |
2018/11/20 | 2,097 | 2,106 | 2,077 | 2,102 | +5 | +0.2% | 48,700 |
2018/11/19 | 2,074 | 2,100 | 2,064 | 2,097 | +18 | +0.9% | 72,100 |
2018/11/16 | 2,087 | 2,094 | 2,062 | 2,079 | -10 | -0.5% | 99,400 |
2018/11/15 | 2,070 | 2,092 | 2,064 | 2,089 | +19 | +0.9% | 49,800 |
2018/11/14 | 2,062 | 2,089 | 2,058 | 2,070 | +8 | +0.4% | 86,800 |
2018/11/13 | 2,074 | 2,079 | 2,050 | 2,062 | -42 | -2% | 87,500 |
2018/11/12 | 2,090 | 2,121 | 2,083 | 2,104 | +11 | +0.5% | 61,700 |
2018/11/09 | 2,074 | 2,112 | 2,074 | 2,093 | +19 | +0.9% | 80,000 |
2018/11/08 | 2,057 | 2,079 | 2,041 | 2,074 | +47 | +2.3% | 56,900 |
2018/11/07 | 2,030 | 2,061 | 2,017 | 2,027 | +2 | +0.1% | 93,000 |
2018/11/06 | 2,030 | 2,034 | 2,001 | 2,025 | +20 | +1% | 140,200 |
2018/11/05 | 2,030 | 2,033 | 1,926 | 2,005 | -110 | -5.2% | 482,300 |
2018/11/02 | 2,078 | 2,126 | 2,078 | 2,115 | +37 | +1.8% | 130,200 |
2018/11/01 | 2,096 | 2,112 | 2,072 | 2,078 | -33 | -1.6% | 74,700 |
2018/10/31 | 2,060 | 2,120 | 2,046 | 2,111 | +38 | +1.8% | 111,900 |
2018/10/30 | 2,012 | 2,073 | 2,009 | 2,073 | +61 | +3% | 317,300 |
2018/10/29 | 2,049 | 2,062 | 2,012 | 2,012 | -24 | -1.2% | 75,700 |
2018/10/26 | 2,090 | 2,092 | 2,025 | 2,036 | -33 | -1.6% | 97,500 |
2018/10/25 | 2,142 | 2,142 | 2,064 | 2,069 | -111 | -5.1% | 89,000 |
2018/10/24 | 2,206 | 2,233 | 2,170 | 2,180 | -10 | -0.5% | 87,200 |
2018/10/23 | 2,263 | 2,263 | 2,187 | 2,190 | -91 | -4% | 114,900 |
2018/10/22 | 2,259 | 2,298 | 2,232 | 2,281 | +23 | +1% | 85,300 |
2018/10/19 | 2,265 | 2,265 | 2,237 | 2,258 | -3 | -0.1% | 62,200 |
2018/10/18 | 2,273 | 2,280 | 2,255 | 2,261 | +6 | +0.3% | 99,700 |
2018/10/17 | 2,233 | 2,262 | 2,227 | 2,255 | +40 | +1.8% | 103,600 |
2018/10/16 | 2,173 | 2,215 | 2,161 | 2,215 | +40 | +1.8% | 119,100 |
2018/10/15 | 2,195 | 2,198 | 2,163 | 2,175 | -48 | -2.2% | 136,800 |
2018/10/12 | 2,282 | 2,291 | 2,221 | 2,223 | -52 | -2.3% | 124,900 |
2018/10/11 | 2,280 | 2,295 | 2,252 | 2,275 | -39 | -1.7% | 125,700 |
2018/10/10 | 2,290 | 2,328 | 2,270 | 2,314 | +23 | +1% | 105,400 |
2018/10/09 | 2,321 | 2,332 | 2,274 | 2,291 | -63 | -2.7% | 160,900 |
2018/10/05 | 2,367 | 2,377 | 2,343 | 2,354 | -40 | -1.7% | 75,200 |
2018/10/04 | 2,441 | 2,441 | 2,365 | 2,394 | -47 | -1.9% | 76,400 |
2018/10/03 | 2,489 | 2,497 | 2,441 | 2,441 | -48 | -1.9% | 73,300 |
2018/10/02 | 2,462 | 2,499 | 2,460 | 2,489 | +16 | +0.6% | 74,600 |
2018/10/01 | 2,493 | 2,505 | 2,466 | 2,473 | -41 | -1.6% | 56,800 |
1451~
1500
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 225,600円 | +13.6% | +29.2% | 2.04% | 11.70倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 479,500円 | +12.0% | +28.1% | 2.50% | 26.43倍 | 1.12倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 332,500円 | +3.0% | +27.5% | 2.41% | 21.05倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 115,700円 | +197.7% | - | 0.00% | 47.28倍 | 1.51倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 150,300円 | +3.2% | +4.5% | 3.46% | 17.27倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム